Clinical Trial Update: Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout [NA]

View source ↗

Summary

This document reports the completion of a clinical trial evaluating a recombinant human TNF receptor II fusion protein for acute gout.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Recombinant human TNF receptor II fusion protein (TNFR2-Fc fusion protein)

Snippet

Sponsor: Lihua Duan | Conditions: Acute Gout | NA | Status: COMPLETED